Relationship between cytochrome P-450 induction by rifampicin, hepatic volume and portal blood flow in man

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 10, 1997, Pages 975-979

  Reichel, Christoph ^a   Block, Wolfgang ^a   Skodra, Thorsten ^a   Träber, Frank ^a   Schiedermaier, Peter ^a   Spengler, Ulrich ^a   Nuber, Richard ^b   Schild, Hans Heinz ^a   Sauerbruch, Tilman ^a  

^a UNIVERSITY OF BONN   (Germany)

^b SANOFI   (France)

Author keywords

6 hydroxycortisol; CYP3A4; Doppler; Induction; Liver volume; Magnetic resonance volumetry; P 450; Portal blood flow; Rifampicin; Ultrasound

Indexed keywords

6BETA HYDROXYHYDROCORTISONE; CYTOCHROME P450; RIFAMPICIN;

ADULT; ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; LIVER METABOLISM; LIVER WEIGHT; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE; ORAL DRUG ADMINISTRATION; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INDUCTION; URINE VOLUME;

EID: 0030794902     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199710000-00010     Document Type: Article

References (29)

1. Remmer H, Merker HJ: Enzyminduktion und Vermehrung von endoplasmatischem Reticulum in der Leberzelle während der Behandlung mit Phenobarbital (Luminal). Klin Wochenschr 1963, 41:276-283.
2. Remmer H: Die Induktion arzneimittelabbauender Enzyme im endoplasmatischen Retikulum der Leberzelle durch Pharmaka. Dtsch Med Wochenschr 1967, 92:2001-2008.
3. Burger PC, Herdson AB, Herdson PB: Phenobarbital-induced fine structural changes in rat liver. Am J Pathol 1966, 48:793-803.
4. Nies AS, Wilkinson GR, Rush BD, et al.: Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat. Biochem Pharmacol 1976, 25:1991-1993.
5. Ohnhaus EE, Thorgeirsson SS, Davies DS, et al.: Changes in liver blood flow during enzyme induction. Biochem Pharmacol 1971, 20:2561-2570.
6. Ohnhaus EE, Locher JTH: Liver blood flow and blood volume following chronic phenobarbitone administration. Eur J Pharmacol 1975, 31:161-165.
7. Branch RA, Shand DG, Wilkinson GR, et al.: Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. J Clin Invest 1974, 53:1101-1107.
8. Ohnhaus EE, Park BK: Measurement of urinary 6-β-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur J Clin Pharmacol 1979, 15:139-145.
9. Hoensch HP, Balzer K, Dylewizc P, et al.: Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. Eur J Clin Pharmacol 1985, 28:475-457.
10. Wietholtz H, Zysset T, Marschall H-U, et al.: The influence of rifampin treatment on caffeine clearance in healthy man. J Hepatol 1995, 22:78-81.
11. Park BK, Kitteringham NR: Assessment of enzyme induction and enzyme inhibition in humans: toxicological implications. Xenobiotica 1990, 20:1171-1185.
12. Gerd C, Rouillon M, Pichard L, et al.: The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Pharmacol 1989, 28:373-387.
13. Fromm MF, Busse D, Kroemer HK, et al.: Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin. Hepatology 1996, 24:796-801.
14. Ohnhaus EE, Noelpp UB, Ramos MR: Liver blood flow and enzyme induction in man. Hepatogastroenterology 1985, 32:61-64.
15. Roberts CJC, Jackson L, Halliwell M, et al.: The relationship between liver volume antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. Br J Clin Pharmacol 1976, 3:907-913.
16. Mergelsberg M, Weber M, Musch E: Liver enlargement under antituberculous combination treatment. Pneumologie 1990, 44:806-814.
17. Pirttiaho HI, Sotaniemi EA, Pelkonen RO, et al.: Hepatic blood \flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur J Clin Pharmacol 1982, 22:441-445.
18. Ono T, Tanida K, Shibata H, et al.: High-performance liquid chromatographic determination of 6 beta-hydroxycortisol in urine. Chem Pharm Bull 1986, 34:2522-2527.
19. Sabbá C, Weltin GG, Cicchetti DV, et al.: Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers. Gastroenterology 1990, 98:1603-1611.
20. Sabbá C, Merkel C, Zolli M, et al.: Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 1995, 21:428-433.
21. Bolognesi M, Sacerdoti D, Merkel C, et al.: Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: comparison between acute and chronic effects. J Hepatol 1997, 26:305-311.
22. Kuo PC, Li K, Alfrey EJ, et al.: Magnetic resonance imaging and hepatic hemodynamics: correlation with metabolic function in liver transplantation candidates. Surgery 1995, 117:373-379.
23. DeLand FH, North WA: Relationship between liver size and body size. Radiology 1968, 91:1195-1198.
24. Carlisle KM, Halliwell M, Read AE, et al.: Estimation of total hepatic blood flow by duplex ultrasound. Gut 1992, 33:92-97.
25. Zentner J, Zoller WG: Indocyanine green clearance and duplex sonography in hepatic blood flow. Clin Invest 1992, 70:620.
26. Bolognesi M, Sacerdoti D, Merkel C, et al.: Relationship between portal blood flow measured by image-directed doppler ultrasonography and hepatic blood flow measured by indocyanine green constant infusion in patients with cirrhosis. J Clin Ultrasound 1995, 23:297-303.
27. Burggraaf J, Schoemaker HC, Cohen AF: Assessment of changes in liver blood flow after food intake comparison of ICG clearance and echo-Doppler. Br J Clin Pharmacol 1996, 42:499-502.
28. Nijeholt GJL, Burggraaf K, Wasser MNJM, et al.: Variability of splanchnic blood flow measurements using MR velocity mapping under fasting and post-prandial conditions - comparison with echo-Doppler. J Hepatol 1997, 26:298-304.
29. Wynne HA, Cope LH, Mutch E, et al.: The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989, 9:297-301.